Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer
- 1 May 2002
- Vol. 59 (5) , 652-656
- https://doi.org/10.1016/s0090-4295(02)01526-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Prostate specific antigen velocity as a measure of the natural history of prostate cancer: defining a ‘rapid riser’ subsetBritish Journal of Urology, 1998
- Prospective Evaluation of Men With Stage T1C Adenocarcinoma of the ProstateJournal of Urology, 1997
- Clinical significance of repeat sextant biopsies in prostate cancer patientsUrology, 1997
- Prospective characterization of pathological features of Prostatic Carcinomas Detected Via Serum Prostate Specific Antigen Based ScreeningJournal of Urology, 1996
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancerPublished by American Medical Association (AMA) ,1994
- Results of Conservative Management of Clinically Localized Prostate CancerNew England Journal of Medicine, 1994
- Relationship between changes in prostate-specific antigen and prognosis of prostate cancerUrology, 1993
- Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volumeCancer, 1993
- Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseJAMA, 1992
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987